• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种不同的结直肠癌KRAS突变筛查方法的比较。

Comparison of two different screening methods for the KRAS mutation in colorectal cancer.

作者信息

Er Tze-Kiong, Chang Ya-Sian, Yeh Kun-Tu, Chang Tien-Jye, Chang Jan-Gowth

机构信息

Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

出版信息

Clin Lab. 2010;56(5-6):175-86.

PMID:20575464
Abstract

BACKGROUND

To compare high resolution melting (HRM) and primer extension (PE) for mutation screening of KRAS codons 12 and 13.

METHODS

DNA samples were isolated from 60 colorectal cancer (CRC) patients. HRM and primer extension analyses were used for mutation screening of KRAS codons 12 and 13.

RESULTS

Both methods can detect KRAS mutations in a DNA mixture containing as little as 5% mutant DNA. The concordant rate between the two methods was 100%. HRM analysis is able to distinguish mutant from wild type, however, it is unable to detect the actual base change. PE analysis needs more procedures, is time-consuming and slightly more expensive but it is able to detect the precise mutation.

CONCLUSIONS

This study showed that HRM is a reliable screening method to identify mutations in the KRAS gene, and the PE can be used as a diagnostic method to accurately pinpoint the nature of mutations.

摘要

背景

比较高分辨率熔解曲线分析(HRM)和引物延伸(PE)用于KRAS基因第12和13密码子突变筛查的效果。

方法

从60例结直肠癌(CRC)患者中分离DNA样本。采用HRM和引物延伸分析对KRAS基因第12和13密码子进行突变筛查。

结果

两种方法均能检测出含有低至5%突变DNA的DNA混合物中的KRAS突变。两种方法的一致率为100%。HRM分析能够区分突变型和野生型,但无法检测出实际的碱基变化。PE分析需要更多步骤,耗时且成本略高,但能够检测出精确的突变。

结论

本研究表明,HRM是一种可靠的KRAS基因突变筛查方法,而PE可作为一种诊断方法准确确定突变的性质。

相似文献

1
Comparison of two different screening methods for the KRAS mutation in colorectal cancer.两种不同的结直肠癌KRAS突变筛查方法的比较。
Clin Lab. 2010;56(5-6):175-86.
2
KRAS mutation testing in colorectal cancer: comparison of the results obtained using 3 different methods for the analysis of codons G12 and G13.结直肠癌中的KRAS突变检测:使用3种不同方法分析密码子G12和G13所获结果的比较
Diagn Mol Pathol. 2012 Mar;21(1):14-23. doi: 10.1097/PDM.0b013e31822b831a.
3
Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay.突变富集 PCR 法检测 KRAS 密码子 12 和 13 突变。
Clin Chim Acta. 2014 Sep 25;436:169-75. doi: 10.1016/j.cca.2014.05.008. Epub 2014 May 24.
4
Unlabeled-probe high-resolution melting to detect KRAS codon 12 and 13 mutations in pancreatic adenocarcinoma tissues.未标记探针高分辨率熔解检测胰腺腺癌组织中 KRAS 密码子 12 和 13 突变。
Clin Chem Lab Med. 2012 Jan 31;50(6):1035-40. doi: 10.1515/cclm-2011-0601.
5
High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer.高分辨率熔解分析用于临床样本中突变的快速灵敏检测:非小细胞肺癌中的KRAS第12和13密码子突变
BMC Cancer. 2006 Dec 21;6:295. doi: 10.1186/1471-2407-6-295.
6
KRAS mutation detection in Tunisian sporadic coloractal cancer patients with direct sequencing, high resolution melting and denaturating high performance liquid chromatography.直接测序、高分辨率熔解和变性高效液相色谱法检测突尼斯散发性结肠直肠癌患者的 KRAS 突变。
Cancer Biomark. 2010;8(6):331-40. doi: 10.3233/CBM-2011-0222.
7
Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.结直肠癌中 KRAS 异构体 KRAS-4A/4B 改变和 KRAS 突变的预后意义。
J Pathol. 2009 Dec;219(4):435-45. doi: 10.1002/path.2625.
8
No duplicate KRAS mutation is identified on the same allele in gastric or colorectal cancer cells with multiple KRAS mutations.在具有多个KRAS突变的胃癌或结肠癌细胞中,同一等位基因上未发现重复的KRAS突变。
J Int Med Res. 2007 Jul-Aug;35(4):450-7. doi: 10.1177/147323000703500403.
9
Comprehensive Validation of Snapback Primer-Based Melting Curve Analysis to Detect Nucleotide Variation in the Codon 12 and 13 of KRAS Gene.基于 Snapback 引物的熔解曲线分析检测 KRAS 基因密码子 12 和 13 核苷酸变异的全面验证。
Biomed Res Int. 2018 Oct 10;2018:8727941. doi: 10.1155/2018/8727941. eCollection 2018.
10
KRAS mutation profile in colorectal carcinoma and novel mutation--internal tandem duplication in KRAS.结直肠癌中的KRAS突变谱及新突变——KRAS基因内部串联重复
Pol J Pathol. 2008;59(2):93-6.

引用本文的文献

1
Circulating Nucleic Acids in Colorectal Cancer: Diagnostic and Prognostic Value.结直肠癌循环核酸:诊断和预后价值。
Dis Markers. 2024 Feb 13;2024:9943412. doi: 10.1155/2024/9943412. eCollection 2024.
2
High-resolution melting for detecting mutations in colorectal cancer.用于检测结直肠癌突变的高分辨率熔解分析
Biomed Rep. 2019 Dec;11(6):269-273. doi: 10.3892/br.2019.1254. Epub 2019 Nov 7.
3
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?
转移性结直肠癌中抗表皮生长因子受体(EGFR)治疗的原发性和获得性耐药新发现:所有途径都通向RAS吗?
Oncotarget. 2015 Sep 22;6(28):24780-96. doi: 10.18632/oncotarget.4959.
4
Computational analysis of KRAS mutations: implications for different effects on the KRAS p.G12D and p.G13D mutations.KRAS 突变的计算分析:对 KRAS p.G12D 和 p.G13D 突变不同影响的意义。
PLoS One. 2013;8(2):e55793. doi: 10.1371/journal.pone.0055793. Epub 2013 Feb 20.
5
KRAS Testing: A Tool for the Implementation of Personalized Medicine.KRAS检测:个性化医疗实施的一种工具。
Genes Cancer. 2012 Jul;3(7-8):459-66. doi: 10.1177/1947601912460547.
6
KRAS mutation detection in paired frozen and Formalin-Fixed Paraffin-Embedded (FFPE) colorectal cancer tissues.配对的冷冻和福尔马林固定石蜡包埋(FFPE)结直肠癌组织中的KRAS突变检测
Int J Mol Sci. 2011;12(5):3191-204. doi: 10.3390/ijms12053191. Epub 2011 May 17.